225 related articles for article (PubMed ID: 18367347)
1. Multiple symmetric lipomatosis - a reflection of new concepts about obesity.
Pandzic Jaksic V; Sucic M
Med Hypotheses; 2008; 71(1):99-101. PubMed ID: 18367347
[TBL] [Abstract][Full Text] [Related]
2. Multiple symmetric lipomatosis. Ultrastructural investigation of the tissue and preadipocytes in primary culture.
Zancanaro C; Sbarbati A; Morroni M; Carraro R; Cigolini M; Enzi G; Cinti S
Lab Invest; 1990 Aug; 63(2):253-8. PubMed ID: 2381166
[TBL] [Abstract][Full Text] [Related]
3. [Multiple symmetrical lipomatosis (MSL): a clinical case and a review of the literature].
Lomartire N; Ciocca F; Di Stanislao C; Bologna G; Giuliani M
Ann Ital Chir; 1999; 70(2):259-62; discussion 262-3. PubMed ID: 10434460
[TBL] [Abstract][Full Text] [Related]
4. Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity.
Bays HE; González-Campoy JM; Bray GA; Kitabchi AE; Bergman DA; Schorr AB; Rodbard HW; Henry RR
Expert Rev Cardiovasc Ther; 2008 Mar; 6(3):343-68. PubMed ID: 18327995
[TBL] [Abstract][Full Text] [Related]
5. Adipose tissue metabolism in benign symmetric lipomatosis.
Nielsen S; Levine J; Clay R; Jensen MD
J Clin Endocrinol Metab; 2001 Jun; 86(6):2717-20. PubMed ID: 11397876
[TBL] [Abstract][Full Text] [Related]
6. Multiple symmetric lipomatosis type 2 in females--report of two cases.
Pandzić Jaksić V; Stoos Veić T
Acta Dermatovenerol Croat; 2008; 16(1):31-4. PubMed ID: 18358107
[TBL] [Abstract][Full Text] [Related]
7. Multiple symmetric lipomatosis: clinical aspects and outcome in a long-term longitudinal study.
Enzi G; Busetto L; Ceschin E; Coin A; Digito M; Pigozzo S
Int J Obes Relat Metab Disord; 2002 Feb; 26(2):253-61. PubMed ID: 11850759
[TBL] [Abstract][Full Text] [Related]
8. [Multiple symmetrical lipomatosis and chronic alcoholism].
Grau Martín A; González-Huix F; Ricart Engel W; Masabeu Urrutia M; Acero Fernández D; Soler Simón S
An Med Interna; 1989 Dec; 6(12):635-8. PubMed ID: 2491474
[TBL] [Abstract][Full Text] [Related]
9. MFN2-associated lipomatosis: Clinical spectrum and impact on adipose tissue.
Capel E; Vatier C; Cervera P; Stojkovic T; Disse E; Cottereau AS; Auclair M; Verpont MC; Mosbah H; Gourdy P; Barraud S; Miquel A; Züchner S; Bonnefond A; Froguel P; Christin-Maitre S; Delemer B; Fève B; Laville M; Robert J; Tenenbaum F; Lascols O; Vigouroux C; Jéru I
J Clin Lipidol; 2018; 12(6):1420-1435. PubMed ID: 30158064
[TBL] [Abstract][Full Text] [Related]
10. [Multiple symmetrical lipomatosis. Metabolic effects of excision of lipomatous tissue].
Melga P; Buzzo P; Accoto S; Cheli V; Prando R
Riv Eur Sci Med Farmacol; 1993; 15(1):11-5. PubMed ID: 8159830
[TBL] [Abstract][Full Text] [Related]
11. Monocyte chemoattractant protein-1 and nitric oxide promote adipogenesis in a model that mimics obesity.
Hemmrich K; Thomas GP; Abberton KM; Thompson EW; Rophael JA; Penington AJ; Morrison WA
Obesity (Silver Spring); 2007 Dec; 15(12):2951-7. PubMed ID: 18198303
[TBL] [Abstract][Full Text] [Related]
12. Fat depot-specific impact of visceral obesity on adipocyte adiponectin release in women.
Drolet R; Bélanger C; Fortier M; Huot C; Mailloux J; Légaré D; Tchernof A
Obesity (Silver Spring); 2009 Mar; 17(3):424-30. PubMed ID: 19219061
[TBL] [Abstract][Full Text] [Related]
13. Multiple symmetric lipomatosis: an unusual cause of childhood obesity and mental retardation.
Kratz C; Lenard HG; Ruzicka T; Gärtner J
Eur J Paediatr Neurol; 2000; 4(2):63-7. PubMed ID: 10817486
[TBL] [Abstract][Full Text] [Related]
14. miR-125a-3p and miR-483-5p promote adipogenesis via suppressing the RhoA/ROCK1/ERK1/2 pathway in multiple symmetric lipomatosis.
Chen K; He H; Xie Y; Zhao L; Zhao S; Wan X; Yang W; Mo Z
Sci Rep; 2015 Jul; 5():11909. PubMed ID: 26148871
[TBL] [Abstract][Full Text] [Related]
15. Multiple symmetric lipomatosis: a rare disease and its possible links to brown adipose tissue.
Enzi G; Busetto L; Sergi G; Coin A; Inelmen EM; Vindigni V; Bassetto F; Cinti S
Nutr Metab Cardiovasc Dis; 2015 Apr; 25(4):347-53. PubMed ID: 25770761
[TBL] [Abstract][Full Text] [Related]
16. Benign symmetric lipomatosis in a 73-year-old man: a case report with a brief review of the literature.
Kise Y; Shimoji M; Toda T; Kiyuna M; Iwasaki H
Rinsho Byori; 2004 Oct; 52(10):824-7. PubMed ID: 15624498
[TBL] [Abstract][Full Text] [Related]
17. Differential clinical expression of multiple symmetric lipomatosis in men and women.
Busetto L; Sträter D; Enzi G; Coin A; Sergi G; Inelmen EM; Pigozzo S
Int J Obes Relat Metab Disord; 2003 Nov; 27(11):1419-22. PubMed ID: 14574355
[TBL] [Abstract][Full Text] [Related]
18. Calcyphosine-like (CAPSL) is regulated in Multiple Symmetric Lipomatosis and is involved in Adipogenesis.
Lindner A; Marbach F; Tschernitz S; Ortner C; Berneburg M; Felthaus O; Prantl L; Kye MJ; Rappl G; Altmüller J; Thiele H; Schreml S; Schreml J
Sci Rep; 2019 Jun; 9(1):8444. PubMed ID: 31186450
[TBL] [Abstract][Full Text] [Related]
19. Multiple symmetric lipomatosis: substantial subcutaneous adipose tissue accumulation did not induce glucose and lipid metabolism dysfunction.
Chen K; Xie Y; Hu P; Zhao S; Mo Z
Ann Nutr Metab; 2010; 57(1):68-73. PubMed ID: 20714139
[TBL] [Abstract][Full Text] [Related]
20. Adipose tissue dysfunction in obesity.
Blüher M
Exp Clin Endocrinol Diabetes; 2009 Jun; 117(6):241-50. PubMed ID: 19358089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
